An extension study to evaluate the long-term safety of Rusfertide (PTG-300) in subjects with Polycythemia Vera

Disease:

Study phase:

Physician name:

Naveen Pemmaraju

Department:

Leukemia

For general questions about clinical trials:

1-877-563-0193